Undercounted Nerve Studies
Electrodiagnostic testing billed generically instead of by nerves and muscles studied.
The fixCode from the technical report and count each nerve and muscle tested.
Nerve studies counted right, injectable therapy fully captured
Neurology revenue sits in two places most billers handle badly. Nerve conduction studies are counted per nerve tested, and injectable therapies carry drug costs larger than the procedure itself. Miss a nerve or a wastage entry and the loss repeats every clinic day. We count from the technical report and verify every drug unit before the claim leaves.
Neurology medical billing covers care for the brain, spine, and nervous system. It spans consultations, electrodiagnostic testing, sleep and seizure monitoring, injectable therapies, and infusion treatment for chronic conditions.
Two areas carry most of the value. Electrodiagnostic studies are billed by how many nerves and muscles were actually tested, so the technical report drives payment directly. Reporting a study generically collapses several billable units into one.
The second is drug spend. Injectable and infused therapies for migraine, multiple sclerosis, and neuromuscular disease cost more than the visit, which makes units, wastage, and authorisation the difference between profit and loss on those patients.
Payment here depends on quantities that live in the technical record, not the visit note.
Electrodiagnostic payment follows the number of nerves and muscles studied, taken from the technical report.
Injectable therapy costs more than the administration, so a units error is far more expensive than usual.
Most high-cost neurology drugs need approval, often after a documented trial of a preferred alternative.
Extended evaluations support higher levels or prolonged services when total time is properly recorded.
Each has a fix your clinic can adopt immediately.
Electrodiagnostic testing billed generically instead of by nerves and muscles studied.
The fixCode from the technical report and count each nerve and muscle tested.
Discarded portions of single-use vials never recorded, giving away recoverable value.
The fixRecord dose given and amount discarded at administration, every time.
Injections or infusions delivered after approval expired, leaving the drug cost unrecovered.
The fixLog approval expiry dates and re-verify before any rescheduled treatment.
Long evaluations billed at a standard level because total time was never documented.
The fixRecord total time on the date of service so the higher path stays available.
Extended monitoring billed globally when the facility supplied the equipment and technicians.
The fixSet the component rule per location instead of deciding claim by claim.
Studies denied because the order shows no symptom or finding justifying them.
The fixState the presenting symptom and clinical question on every test order.
Testing and infusion workflows handled as separate tracks.
Coverage is confirmed and any therapy the plan gates is identified before the patient is scheduled.
High-cost therapy requests go out with diagnosis, prior treatments tried, and response documented.
Electrodiagnostic claims are built from the technical report, nerve by nerve and muscle by muscle.
Every injection and infusion claim is checked for correct units and documented wastage before transmission.
Long evaluations are reviewed for total time so prolonged services are billed when supported.
Denials are appealed with the technical record attached, and drug revenue is reported separately.
Drug billing and authorisation tracking included.
A general map of neurology coding.
| Range | What It Covers |
|---|---|
| 95907–95913 | Nerve conduction studies by number of nerves tested |
| 95860–95887 | Needle electromyography by extremity and region |
| 95700–95726 | Electroencephalography and long-term monitoring |
| 95782–95811 | Polysomnography and sleep studies |
| 64612–64647 | Chemodenervation and nerve injection procedures |
| 96365–96379 | Infusion and injection administration |
| Group | Clinical Focus |
|---|---|
| G40–G41 | Epilepsy and recurrent seizures |
| G43–G44 | Migraine and other headache syndromes |
| G35–G37 | Multiple sclerosis and demyelinating disease |
| G20–G26 | Parkinson disease and movement disorders |
| G56–G59 | Nerve entrapment and peripheral neuropathies |
| G30–G31 | Alzheimer disease and other degenerative conditions |
Note: This is general education on how neurology coding is organised. Code sets and payer policies change often. Always check the current code set and the payer's active policy for the date of service.
We bill inside the platform your practice already runs.
Solutions for neurology and headache practices.
By the number of nerves actually studied, taken from the technical report rather than the order. Payment tiers rise with the count, so a study reported generically collapses several billable units into one. Ask your technologist to list every nerve and muscle tested. We build these claims from that list, which is usually the largest single recovery in a neurology practice.
Very likely. Single-use vials often contain more than one patient needs, and the discarded portion is recoverable when documented. Practices that record only the administered dose give the rest away. Record both the dose given and the amount discarded at the time of administration. We verify these figures on every claim, and the recovered value adds up quickly.
Showing the treatment history. Most high-cost neurology drugs require evidence that a preferred alternative was tried and did not work well enough. Requests carrying only a diagnosis get pended for records. Submit the prior therapies, how long each was used, and the documented response. We assemble that history up front, which shortens approval time considerably.
Yes, when total time on the date of service is recorded. Neurology visits regularly run well beyond a standard slot, and prolonged service billing exists for exactly that. The requirement is a number in the note, not a description of how long it felt. Adding total time to your template keeps the higher-paying path available on every complex visit.
Because it was billed globally while the facility supplied the equipment and technical staff. In that arrangement you bill only the interpretation, and the facility bills the technical portion. Billing the whole study collides with theirs. We set this rule per location during onboarding so the split is applied automatically rather than judged case by case.
Put the clinical question on the order. Electrodiagnostic and imaging studies denied for necessity almost always came from orders showing a diagnosis but no symptom or finding. State what prompted the test and what you are trying to rule out. That single line usually converts the denial into a payment, and it strengthens any appeal you still need.
As a procedure plus the drug, with units driving most of the value. The injection code depends on the muscles treated, and the drug is billed separately by units used, with wastage recorded where applicable. Many plans also require a documented trial of preventive medication first. We track authorisation and verify units on every treatment cycle.
Re-verify the authorisation before they arrive. Approvals carry expiry dates, and infusion appointments move frequently for clinical and personal reasons. A therapy given a week past the approved window is usually unrecoverable, and in neurology that means absorbing a very large drug cost. We re-check every rescheduled treatment as standard practice.
Yes. The key variables are where the study was performed and whether your practice supplied the equipment or only the interpretation. Home and in-laboratory studies bill differently, and some plans require a home study first. We configure the component rule per site and check the plan's site-of-service requirement before the study is scheduled.
Rebuilding how electrodiagnostic studies are counted. Most practices report them at a level below what was actually performed, and the gap repeats every testing day. Comparing one month of technical reports against billed units almost always reveals it. The correction is a coding process change, not a clinical one, so the improvement appears in the next cycle.
We compare a month of technical reports and drug records against your submitted claims, then show you the undercounted studies and unbilled wastage.
Submit your details and our AAPC-certified billing auditors will coordinate a free operational audit for your clinic.
Prefer booking a direct 30-minute online calendar slot with our director of RCM?
Book Direct Meeting